August 2010. pharmtrace relocate from Friedrichstraße to new offices (Alt Moabit 60, 10555 Berlin). The new offices are also located in the central Berlin area and can be easily reached by public transport connections. Relocation to new bigger premises necessitated by increased staff number in response to continued success in winning new studies.
July 2010. pharmtrace, together with 4 partners, receives public funding for the AQUADIC project from the "KMU innovativ" program of the German Federal Ministry of Education and Research. The AQUADIC project aimes at optimizing the collection, quality control, storage and controlled visualization of radiological images for scientific analysis. The overall budget of AQUADIC is almost 1.4 million Euro for the next 2 years. For more information please contact wiebke.loch(at)pharmtrace.com.
April 2010. pharmtrace is accepted by the French Ministry of Higher Education and Research as an organisation carrying out R&D activities for the account of private companies (crédit d'impôt recherche - CIR)
February 2010. Defined - together with experts from the pharmtrace imaging network - the technical prerequisites for the qualification of clinical and imaging centers for an 800 patient cancer study which involves invasive therapeutic interventions and CT and MRI imaging
October 2009. pharmtrace participates in the 5th Annual Global Imaging Summit in Berlin. Wolf-Stefan Richter is a speaker at the summit and also wrote an article entitled Drug Development in the Era of Molecular Medicine for the Global Outsourcing Review 2009 (Link to article)
August 2009. Blinded read and truth panel assessment successfully completed (start to finish - 6 weeks - from initial discussion to provision of completed statistical analysis) in time for review by EMEA
May 2009. pharmtrace all SOPs updated to improve operational efficiency and adaptability of working procedures focused on robust information collection, evaluation and exchange systems between pharmtrace, clinical/imaging centres and study sponsors. New procedures allow pharmtrace to adapt its SOPs, whilst maintaining quality and data integrity, to take account of sponsors’ internal systems
February 2009. pharmtrace awarded contract to assist with the design, protocol preparation and study set-up (incl. imaging site qualification and selection criteria) for an 800 patient multinational clinical trial with multiple end-points including imaging
December 2008. Meet pharmtrace at IIR’s preclinical and clinical imaging summit in Cologne
October 2008. The first blinded read of almost 100 patients with several MR sequences each including statistical analysis is successfully completed in time
September 2008. Pharmtrace contributes the 3rd time to the “biotech and pharma business summer school” in Berlin-Buch, Germany
July 2008. pharmtrace’s first GCP training for investigators with more than 30 participants successfully completed at the University of Magdeburg, Germany
April 2008. Completion and on time delivery of the results of one of the first clinical trials pharmtrace designed and managed to the regulatory authorities
September 2007. Eckert & Ziegler sell their complete shareholding to the other original pharmtrace shareholders
July 2007. pharmtrace moves its offices to Friedrichstrasse in central Berlin. The location is next door to Friedrichstrasse train stations. "Unter den Linden" and the Brandenburg gate are close and within a shortwalking distance
December 2006. pharmtrace signs master service agreements with the Charité, Berlin, Germany, and the Policlinico in Milan, Italy, to guarantee access to leading edge multimodal medical imaging facilities with large and varied patient populations
June 2006. pharmtrace is founded